Trial Profile
A Randomized, Double-Blind, Parallel, Placebo or Amlodipine-Controlled Study of the Effects of Losartan on Proteinuria in Pediatric Patients With or Without Hypertension.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Losartan (Primary) ; Amlodipine; Enalapril
- Indications Hypertension
- Focus Pharmacodynamics
- Sponsors Organon
- 16 May 2019 This trial has benn completed in Spain as per European Clinical Trials Database record.
- 05 Nov 2011 Status changed from active, no longer recruiting to completed as reported by UKCRN.
- 25 Feb 2011 Planned end date changed from 1 Feb 2011 to 1 Mar 2011 as reported by ClinicalTrials.gov.